Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-006365
Date:2021-01-28
Issuer: RELAY THERAPEUTICS, INC. (RLAY)
Original Submission Date:

Reporting Person:

ADAMS BRIAN
C/O RELAY THERAPEUTICS, INC.
399 BINNEY STREET, 2ND FLOOR CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-01-28 M 5,000 a $4.12 15,000 direct
COMMON STOCK 2021-01-28 S 5,000 d $55.05 10,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 4.12 2021-01-28 deemed execution date M 5,000 (d) 2028-03-22 common stock 5,000 $4.12 166,786 direct
Footnotes
IDfootnote
f1 this transaction was executed in multiple trades at prices ranging from $55.00 to $55.24. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request by the staff of the securities and exchange commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
f2 twenty-five percent (25%) of the shares underlying this option vested on march 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Elevate your investments